Trial intelligence / Profile preview

Post-marketing safety evaluation of Danhong injection

ChiCTR-OCS-12002523Phase 4Completed

Sponsor
First Affiliated Hospital of Henan University of Chinese Medicine
Start
Aug 2011
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of danhong injection in Noninfectious Diseases, sponsored by First Affiliated Hospital of Henan University of Chinese Medicine. Primary endpoints: Safety, Adverse reaction incidence and 2 more. Started Aug 2011; status: completed.

02

Drugs

danhong injection
03

Conditions

Noninfectious Diseases

Beyond the preview

Go deeper on ChiCTR-OCS-12002523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OCS-12002523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call